The in vivo diagnosis of synucleinopathies is an important research aim since clinical diagnostic criteria show low accuracy. The skin innervation, especially the autonomic subdivision, is a useful region to search for abnormal α-syn aggregates in synucleinopathies since the peripheral sympathetic nerves can be the earliest-affected neural region and autonomic symptoms may precede the classical symptoms of these disorders.
The major advantages of skin biopsy as an in vivo diagnostic tool for synucleinopathies are that it is an inexpensive and easy-to-perform technique requiring only limited facilities, and that it is repeatable in long-term studies as it causes only minor discomfort to the patient.
This review analyzes current progress in this area of research that may facilitate the standardization of this method, potentially eliminating differences among laboratories in the implementation of the method.
The most suitable and commonly used technique for identifying in vivo α-syn aggregates in skin nerves is indirect immunofluorescence, although several aspects of this approach need to be standardized, particularly when synucleinopathies without autonomic failure present a patchy distribution of abnormal α-syn aggregates in skin nerves. By contrast, synucleinopathies with autonomic failure may present widespread diffusion of abnormal aggregates in autonomic skin nerves.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
George S, Rey NL, Reichenbach N, Steiner JA, Brundin P (2013) α-Synuclein: the long distance runner. Brain Pathol 23(3):350–357
Dorsey ER, Constantinescu R, Thompson JP et al (2007) Projected number of 408. People with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384–386
McKeith IG, Dickson DW, Lowe J et al (2005) Consortium on DLB: diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872
Goldstein DS, Sharabi Y (2017) The heart of PD: Lewy body diseases as neurocardiologic disorders. Brain Res. https://doi.org/10.1016/j.brainres.2017.09.033
Adler CH, Beach TG, Hentz JG et al (2014) Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology 83:406–412
Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, Liguori R, Logroscino G (2018) Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 89(4):358–366
Kaufmann H, Nahm K, Purohit D, Wolfe D (2004) Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63(6):1093–1095
Probst A, Bloch A, Tolnay M (2008) New insights into the pathology of Parkinson’s disease: does the peripheral autonomic system become central? Eur J Neurol 15(Suppl 1):1–4
Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426
Ikemura M, Saito Y, Sengoku R, Sakiyama Y, Hatsuta H, Kanemaru K, Sawabe M, Arai T, Ito G, Iwatsubo T, Fukayama M, Murayama S (2008) Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 67(10):945–953
Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG (2010) Arizona Parkinson’s Disease Consortium. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119(6):689–702
Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, Martí MJ, Hernández I, Valldeoriola F, Reñé R, Ribalta T (2014) Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord 29(8):1010–1018
Gibbons CH, Wang N, Freeman R (2017) Cutaneous alpha-synuclein from paraffin embedded autopsy specimens in Parkinson’s disease. J Parkinsons Dis 7(3):503–509
Miki Y, Tomiyama M, Ueno T, Haga R, Nishijima H, Suzuki C, Mori F, Kaimori M, Baba M, Wakabayashi K (2010) Clinical availability of skin biopsy in the diagnosis of Parkinson’s disease. Neurosci Lett 469(3):57–59
Wang N, Gibbons CH, Lafo J, Freeman R (2013) α-Synuclein in cutaneous autonomic nerves. Neurology 81(18):1604–1610
Doppler K, Ebert S, Uçeyler N, Trenkwalder C, Ebentheuer J, Volkmann J, Sommer C (2014) Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology. Acta Neuropathol 128(1):99–109
Donadio V, Incensi A, Cortelli P, Giannoccaro MP, Jaber MA, Baruzzi A, Liguori R (2013) Skin sympathetic fiber α-synuclein deposits: a potential biomarker for pure autonomic failure. Neurology 80(8):725–732
Donadio V, Incensi A, Leta V, Giannoccaro MP, Scaglione C, Martinelli P et al (2014) Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease. Neurology 82(15):1362–1369
Donadio V, Incensi A, Piccinini C, Cortelli P, Giannoccaro MP, Baruzzi A, Liguori R (2016) Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease. Ann Neurol 79(2):306–316
Donadio V, Incensi A, Rizzo G, Capellari S, Pantieri R, Stanzani Maserati M, Devigili G, Eleopra R, Defazio G, Montini F, Baruzzi A, Liguori R (2017) A new potential biomarker for dementia with Lewy bodies: skin nerve α-synuclein deposits. Neurology 89(4):318–326
Doppler K, Weis J, Karl K, Ebert S, Ebentheuer J, Trenkwalder C, Klebe S, Volkmann J, Sommer C (2015) Distinctive distrubution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy. Mov Disord 30(12):1688–1692
Gibbons CH, Garcia J, Wang N, Shih LC, Freeman R (2016) The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease. Neurology 87(5):505–512
Navarro-Otano J, Casanova-Mollà J, Morales M, Valls-Solé J, Tolosa E (2015) Cutaneous autonomic denervation in Parkinson’s disease. J Neural Transm (Vienna) 122(8):1149–1155
Zange L, Noack C, Hahn K, Stenzel W, Lipp A (2015) Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson’s disease from multiple system atrophy. Brain 138(Pt 8):2310–2321
Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH (2017) Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease. Acta Neuropathol 133(4):535–545
Antelmi E, Donadio V, Incensi A, Plazzi G, Liguori R (2017) Skin nerve phosphosylated α-synuclein deposits in idiopathic REM sleep behavior disorder. Neurology 88(22):2128–2131
Donadio V, Doppler K, Incensi A, Kuzkina A, Janzen A, Mayer G, Volkmann J, Rizzo G, Antelmi E, Plazzi G, Sommer C, Liguori R, Oertel WH (2018) Abnormal α-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility. Eur J Neurol (submitted)
Beach TG, White CL, Hamilton RL, Duda JE, Iwatsubo T, Dickson DW, Leverenz JB, Roncaroli F, Buttini M, Hladik CL, Sue LI, Noorigian JV, Adler CH (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 116(3):277–288
Shin C, Park SH, Yun JY, Shin JH, Yang HK, Lee HJ, Kong SH, Suh YS, Kim HJ, Jeon B (2018) Alpha-synuclein staining in non-neural structures of the gastrointestinal tract is non-specific in Parkinson disease. Parkinsonism Relat Disord. 55:15-–17. https://doi.org/10.1016/j.parkreldis.2018.09.026
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840
Lee JM, Derkinderen P, Kordower JH, Freeman R, Munoz DG, Kremer T, Zago W, Hutten SJ, Adler CH, Serrano GE, Beach TG (2017) The search for a peripheral biopsy indicator of α-synuclein pathology for Parkinson disease. J Neuropathol Exp Neurol 76(1):2–15
Donadio V, Incensi A, El-Agnaf O, Rizzo G, Vaikath N, Del Sorbo F, Scaglione C, Capellari S, Elia A, Stanzani Maserati M, Pantieri R, Liguori R (2018) Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study. Sci Rep 8(1):14246. https://doi.org/10.1038/s41598-018-32588-8
Donadio V, Incensi A, Del Sorbo F, Rizzo G, Infante R, Scaglione C, Modugno N, Fileccia N, Elia AE, Cencini F, Liguori R (2018) Skin nerve phosphorylated α-synuclein deposits in Parkinson’s disease with orthostatic hypotension. J Neuropathol Exp Neurol 77:942–949. https://doi.org/10.1093/jnen/nly074
Donadio V, Incensi A, Rizzo G, Scaglione C, Capellari S, Fileccia E et al (2017) Spine topographical distribution of skin α-synuclein deposits in idiopathic Parkinson disease. J Neuropathol Exp Neurol 76:384–389
Conflict of interest
There is no conflict of interest to report for this manuscript.
About this article
Cite this article
Donadio, V. Skin nerve α-synuclein deposits in Parkinson’s disease and other synucleinopathies: a review. Clin Auton Res 29, 577–585 (2019). https://doi.org/10.1007/s10286-018-0581-4
- Phosphorylated α-synuclein
- Skin biopsy
- Pure autonomic failure
- Idiopathic Parkinson’s disease
- Dementia with Lewy bodies